outgoing Infinity Pharmaceuticals CEO Adelene Perkins and CMO Robert Ilaria

Fall­out from failed MEI merg­er con­tin­ues as In­fin­i­ty's CEO, CMO ex­it

In­fin­i­ty Phar­ma­ceu­ti­cals CEO Ade­lene Perkins and CMO Robert Ilar­ia were ter­mi­nat­ed “with­out cause” from their roles on Sept. 1 as a part of the com­pa­ny’s so-called “Au­gust re­struc­tur­ing.” CSO Stéphane Pelu­so al­so ex­it­ed the com­pa­ny.

The Cam­bridge, MA-based com­pa­ny is still grap­pling with MEI Phar­ma scrap­ping its all-stock merg­er with In­fin­i­ty on Ju­ly 24 due to poor share­hold­er sup­port. These three ex­its are de­signed to save the com­pa­ny mon­ey and are on top of its head­count re­duc­tion of 21 peo­ple — 78% of its em­ploy­ees — right af­ter the failed merg­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.